Rare diseases
Investigational molecules
Locations
Back to Italy2 668 clinical trials in Ranica, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Patidegib Gel for Reducing Basal Cell Carcinomas in Adults with Gorlin Syndrome
ItalyStudy on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
ItalyStudy on Povetacicept for Patients with Autoimmune Cytopenias (wAIHA, CAD, ITP)
ItalyStudy on the Safety and Tolerability of BMS-986435 in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
ItalyStudy on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma
ItalyStudy of Farletuzumab Ecteribulin vs. Chemotherapy for Women with Platinum-resistant High-grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ItalyStudy of VRDN-001 for Patients with Thyroid Eye Disease Who Did Not Respond to Previous Treatment
ItalyStudy of Emrusolmin for Treating Adults with Multiple System Atrophy
ItalyStudy on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease
ItalyStudy on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months - 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors
ItalyStudy of Durvalumab, Tremelimumab, and Lenvatinib with TACE for Patients with Liver Cancer (Hepatocellular Carcinoma)
ItalyStudy on Long-Term Safety of Donidalorsen for Patients with Hereditary Angioedema
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.
Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.
Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.
Focus on proteinuria reduction and preservation of renal function in various nephropathy types.
Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.
Studies aim to delay disease progression and improve standard of care outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
